ROS-responsive liposomes as an inhaled drug delivery nanoplatform for idiopathic pulmonary fibrosis treatment via Nrf2 signaling
Junzhao Liu(Dalian Medical University), Zhigang Wang(Dalian Medical University)
Cited by 125
Related Papers
Comprehensive dry eye therapy: overcoming ocular surface barrier and combating inflammation, oxidation, and mitochondrial damage
|Journal of Nanobiotechnology|2024|49
Cyclovirobuxine inhibits the progression of clear cell renal cell carcinoma by suppressing the IGFBP3-AKT/STAT3/MAPK-Snail signalling pathway
|International Journal of Biological Sciences|2021|40